Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

Published:2024-06 Issue: Volume:204 Page:114044
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Zwart Wouter H.,Temmink Sofieke J.D.,Hospers Geke A.P.,Marijnen Corrie A.M.,Putter Hein,Nagtegaal Iris D.,Blomqvist Lennart,Kranenbarg Elma Meershoek-Klein,Roodvoets Annet G.H.,Martling Anna,van de Velde Cornelis J.H.,Glimelius Bengt,Peeters Koen C.M.J.,van Etten Boudewijn,Nilsson Per J.

Funder

Spanish Clinical Research Network

Carlos III Health Institute

Swedish Cancer Society

Horizon 2020

Dutch Cancer Society

China Academy of Space Technology

Cancer Couch Foundation

European Regional Development Fund

Vetenskapsrådet

H2020 Marie Skłodowska-Curie Actions

Ministerio de Economía y Competitividad

Horizon 2020 Framework Programme

Horizon 2020 European Innovation Council Fast Track to Innovation

Publisher

Elsevier BV

Reference29 articles.

1. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology;Benson;J Natl Compr Canc Netw,2022

2. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data;Maas;Lancet Oncol,2010

3. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence;de Campos-Lobato;Ann Surg Oncol,2011

4. Tumour regression after radiotherapy for rectal cancer - results from the randomised Stockholm III trial;Erlandsson;Radio Oncol,2019

5. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial;Bahadoer;Lancet Oncol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: “Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer,” by Goffredo et al. Without Constancy There is Neither Love, Friendship, Nor Virtue in the World;Annals of Surgical Oncology;2024-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3